We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arch Therapeutics Inc (QB) | USOTC:ARTH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.48 | 1.48 | 1.77 | 1.48 | 1.20 | 1.48 | 2,972 | 15:01:31 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
FORM 8-K
|
CURRENT REPORT
|
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934 |
Date of Report (Date of earliest event reported): March 7, 2023
|
ARCH THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
|
Nevada
|
000-54986
|
46-0524102
|
(State or other jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
235 Walnut Street, Suite 6 | ||
Framingham, Massachusetts | 01702 | |
(Address of principal executive offices) | (Zip Code) |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
N|A
|
N|A
|
N|A
|
Item 8.01.
|
Other Events.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit No. | Description | |
99.1
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
ARCH THERAPEUTICS, INC.
|
|||
Dated: March 7, 2023
|
By:
|
/s/ Terrence W. Norchi, M.D.
|
|
Name: Terrence W. Norchi, M.D.
|
|||
Title: President, Chief Executive Officer
|
1 Year Arch Therapeutics (QB) Chart |
1 Month Arch Therapeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions